Lymphocyte inhibition by mammary tumor virus in patients with breast cancer.
D000818:Animals; D000956:Antigens, Viral; D001941:Breast Diseases / Q000276:immunology; D001943:Breast Neoplasms / Q000276:immunology*; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006649:Histocompatibility Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000276:immunology*; D008324:Mammary Tumor Virus, Mouse / Q000276:immunology* / Q000302:isolation & purification; D051379:Mice; D008892:Milk / Q000382:microbiology; D013601:T-Lymphocytes / Q000276:immunology
D000956:Antigens, Viral; D006649:Histocompatibility Antigens; D007106:Immune Sera; D037102:Lectins